Home \ Neuropediatrics
Library

Neuropediatry

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The value of mitochondrial dysfunction in stabilization
The value of mitochondrial dysfunction in stabilization
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
The value of mitochondrial dysfunction in stabilization
The value of mitochondrial dysfunction in stabilization
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods
The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

Cognitive dysfunction in children with nervous system diseases: modern approaches to diagnosis and treatment

S.A. NEMKOVA

Federal State Autonomous Educational Institution of Higher Education "N.I. Pirogov Russian National Research Medical University" of the Ministry of Health of the Russian Federation,
Moscow, Russia

Place of publication:
S.S. Korsakov Journal of Neurology and Psychiatry 2025, Vol. 125, No. 10, Issue 2, pp. 69–79
https://doi.org/10.17116/jnevro202512510269

Read more

Attention Deficit Hyperactivity Disorder - Clinical Manifestations from Child to Adult

Authors:
L. S. Chutko, Professor, Doctor of Medical Sciences, Head of the Laboratory for Correction of Mental Development and Adaptation, Head of the Center for Behavioral Neurology at the N.P. Bekhtereva Institute of the Human Brain of the Russian Academy of Sciences, Professor at the Department of Family Medicine at the Faculty of Preparatory and Continuing Professional Education at the Saint Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia

E. A. Yakovenko, Ph.D., researcher at the Institute of the Human Brain named after. N.P. Bekhtereva Russian Academy of Sciences, St. Petersburg, Russia

S. Yu. Surushkina, neurologist, PhD, research fellow at the N.P. Bekhtereva Institute of the Human Brain of the Russian Academy of Sciences, St. Petersburg, Russia

Read more

The possibility of using Mexidol in neuropediatrics

Authors:
N.N. ZAVADENKO, N.YU. SUVORINOVA, A.N. ZAVADENKO

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Read more

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

Registered on ClinicalTrials 

 

N.N. ZAVADENKO1, N.Yu. SUVORINOVA1, T.T. BATYSHEVA2, O.V. BYKOVA2, A.N. PLATONOVA2, D.D. GAYNETDINOVA3, E.V. LEVITINA4, V.V. MASHIN5, I.N. VAKULA6, N.E. MAKSIMOVA7

1Pirogov Russian National Research Medical University, Moscow, Russia;
2Scientific and Practical Center for Child Psychoneurology, Moscow Department of Health, Moscow, Russia;
3Kazan State Medical University, Kazan, Russia;
4Tyumen State Medical University, Tyumen, Russia;
5Ulyanovsk State University, Ulyanovsk, Russia;
6Center for Professional Therapy, Krasnodar, Russia.

7FSBEI in the Tver State Medical University, Tver, Russia

 

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2022, Vol. 122, No. 4

Read more

Experience in the use of Mexidol® in children and adolescents with mental disorders

Authors:
Yu.Sh. Vasyanina

Read more

The use of Mexidol® in children's neurological practice

Authors:
G.R. KHAMITOVA

Read more

The use of Mexidol in the correction of vegetative dizregulation syndrome as the consequences of perinatal lesions of the central nervous system

Authors:
M.A. OKUNEVA

Read more

The course of school adaptation in children with syndrome of attention deficiency with hyperactivity against the background of the use of Mexidol

Authors:
I.S. POTAPOVA, N.V. KHROMINA, M.V. PROTOPOPOVA

Read more

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com